Paper funded by the Myrovlytis Trust published

Yan et al. (2014) find that FLCN inhibits AMPK by binding to it, which prevents cells from tumorigenic Warburg transformation.

This work was partly funded by the Myrovlytis Trust, through grants awarded to Professor Arnim Pause, at McGill University, Montréal, Canada and Dr Andy Tee at Cardiff University, UK.